Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 21437 for:    United Therapeutics cell
Previous Study | Return to List | Next Study

Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

This study has been terminated.
Information provided by (Responsible Party):
United Therapeutics Identifier:
First received: February 12, 2013
Last updated: February 15, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)